Sunday 18 October 2026 Export DYNTQ’s income statement to Excel — free account

Dynatronics Corporation

Dynatronics Corporation’s revenue for fiscal 2025 (year ended June 2025) was $27.4 million, down 15.8% from fiscal 2024. In the quarter to September 2025, revenue fell 7.61%, EPS grew 66.7% and free cash flow fell 193.0%, each against the same quarter a year earlier.

0.00 0.00 NaN

Follow DYNTQ

Alert me

Market cap: $1.2M
P/E: 0.0×
Fwd P/E: −1.5×
Dividend yield: —
F-score: 3/9
Altman Z: −2.33
Beneish M: −6.52
Dividend safety: n/a

Overview Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership 82.28%

Capital & Financial Ratios $m

Market Cap 1.18

Revenue 26.81

Net Income (10.74)

Free Cash Flow 0.08

Net Debt 2.82

Current Ratio 1.07

Debt/Equity 1.19

P/E ratio 0.00

Fwd P/E (1.51)

P/S ratio 0.00

P/B ratio 0.00

Past 5Y EPS Growth —

This Y EPS Growth 37.00%

Next Y EPS Growth —

Next Y revenue growth 13.73%

Next 5Y EPS Growth —

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

EV/Sales against its own 10 years 0.37%

10-year low 10-year high

EV/FCF against its own 10 years 58.08%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2024	Powerpack
2023	Powerpack
2022	Powerpack
2021	Powerpack
2020	Powerpack
2017	Powerpack

special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'25
Cash	1	1	0	1
Receivables	4	4	3	3
Inventory	7	6	5	5
Other	—	—	—	—
	12	11	9	9

	2023	2024	2025	Q'25
Payables	5	3	3	3
ST’ Debt	1	2	2	3
Other	0	0	0	0
	8	8	8	8

Compound Annual Growth %

	10y	5y	3y
Sales	(0.61%)	(12.50%)	(14.83%)
Cash Flow	0.00%	(37.25%)	0.00%
Earnings	0.00%	0.00%	0.00%
Book Value	(7.75%)	(30.35%)	(46.83%)

Revenue $m

	Sep	Dec	Mar	Jun	Year
’26	7	—	—	—	—
’25	8	7	6	6	27
’24	9	8	8	7	33
’23	12	11	9	8	41
’22	12	11	10	11	44
’21	12	12	11	12	48
’20	16	15	14	8	53

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Sep	Dec	Mar	Jun	Year
’26	0	—	—	—	—
’25	0	0	0	0	0
’24	(2)	0	0	0	(2)
’23	0	0	0	0	0
’22	(1)	(2)	(1)	(2)	(5)
’21	1	2	(2)	0	0
’20	2	1	0	1	3

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Sep	Dec	Mar	Jun	Year
’26	0	—	—	—	—
’25	0	0	0	0	0
’24	(2)	0	0	0	(2)
’23	0	0	0	0	0
’22	(1)	(2)	(1)	(2)	(5)
’21	1	1	(2)	2	2
’20	2	1	0	0	3

Fiscal quarters ending in the months shown.

EPS $

	Sep	Dec	Mar	Jun	Year
’26	(0.03)	—	—	—	—
’25	(0.09)	(0.13)	(0.13)	(1.06)	(1.43)
’24	(0.12)	(0.27)	(0.17)	(0.35)	(1.00)
’23	(0.20)	(0.27)	(0.36)	(0.63)	(1.46)
’22	0.10	(0.45)	(0.45)	(0.50)	(1.30)
’21	(0.20)	(0.30)	0.00	0.80	0.40
’20	(0.05)	(0.25)	(0.65)	(1.11)	(2.10)

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	11.44	10.50	11.85	3.15	2.61	4.00	1.50	0.47	0.08	0.04	Analyst estimates 2026–2028 Powerpack
	High	16.05	18.75	18.00	14.20	18.50	12.80	5.35	2.73	0.73	0.19
People
People	Employees	153	233	336	284	195	175	197	156	112	88
	Revenue/emp, $m	0.20	0.15	0.19	0.22	0.27	0.27	0.23	0.26	0.29	0.31
Income, $m
Income, $m	Revenue	30	36	64	63	53	48	44	41	33	27
	Gross margin, %	34.05	32.18	31.70	30.65	28.27	26.96	24.07	24.99	23.47	21.94
	EBT	(2)	(2)	(2)	(1)	(3)	2	(4)	(5)	(3)	(11)
	EBT margin, %	(6.47)	(5.22)	(2.60)	(1.46)	(6.43)	4.17	(9.01)	(12.25)	(8.29)	(39.75)
	Net income	(2)	(2)	(2)	(1)	(3)	2	(4)	(5)	(3)	(11)
	Depreciation	1	1	1	2	2	1	1	1	1	8
Per share, $
Per share, $	Revenue	56.19	56.72	48.64	37.94	26.02	15.46	12.42	10.49	9.51	3.37
	Earnings	(4.20)	(6.80)	(2.65)	(1.05)	(2.10)	0.40	(1.30)	(1.46)	(1.00)	(1.43)
	Cash flow	(0.99)	(2.42)	0.58	0.20	1.51	0.12	(1.37)	0.10	(0.47)	0.04
	Capex	(0.36)	(0.14)	(0.17)	(0.14)	(0.14)	0.50	(0.09)	(0.05)	(0.07)	0.00
	Free cash flow	(1.35)	(2.56)	0.40	0.06	1.36	0.62	(1.46)	0.05	(0.54)	0.03
	Book value	10.33	19.55	16.14	12.59	9.69	8.25	6.08	4.35	4.14	0.40
	Shares, m	1	1	1	2	2	3	4	4	3	8
Valuation, ×
Valuation, ×	P/E	0.00	0.00	0.00	0.00	0.00	20.00	0.00	0.00	0.00	0.00
	P/S	0.26	0.25	0.30	0.22	0.17	0.39	0.25	0.07	0.02	0.02
	P/B	4.28	2.31	2.01	1.54	0.81	1.06	0.79	0.33	0.12	0.00
	EV/Sales	0.36	0.40	0.43	0.38	0.26	0.31	0.27	0.13	0.12	0.12
	EV/FCF	(15.11)	(8.95)	51.91	231.51	4.98	7.62	(2.33)	29.56	(2.03)	12.61
Cash, $m
Cash, $m	Operating cash flow	(1)	(2)	1	0	3	0	(5)	0	(2)	0
	Capex	0	0	0	0	0	2	0	0	0	0
	Free cash flow	(1)	(2)	1	0	3	2	(5)	0	(2)	0
Balance, $m
Balance, $m	Working capital	6	6	7	6	8	12	9	4	3	1
	Total debt	4	6	10	10	7	2	2	3	4	3
	Net debt	3	6	8	10	5	(4)	1	3	3	3
	Shareholders’ equity	6	12	21	21	20	26	22	17	14	3
Returns, %
Returns, %	ROA	(13.21)	(20.77)	(10.27)	(4.20)	(11.18)	3.15	(12.68)	(17.30)	(12.24)	(56.08)
	ROIC	(12.33)	(5.83)	(2.66)	(1.64)	(7.54)	(10.91)	(12.96)	(15.63)	(8.27)	(25.59)
	ROE	(83.35)	(150.56)	(51.61)	(18.21)	(42.66)	8.44	(30.25)	(50.14)	(45.55)	(1,588.36)

Negative figures in brackets.

All 10 years →

Fiscal years to Jun 2025 · latest quarter Sep 2025

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
NUVOQ Holdco Nuvo Group D.G Ltd.	$2.1M	— (loss-making)	—	—	n/m	−1.05% (below 0%: shrinking)	0.00%	0.00%	Compare
VJET Flyte Aviation, Inc.	$2.1M	— (loss-making)	— (loss-making)	+380.66% (above 0%: growing)	n/m	−26.70% (below 0%: shrinking)	9.62%	(388.13%)	Compare
NUWE Nuwellis, Inc.	$2.0M	— (loss-making)	— (loss-making)	+14.14% (above 0%: growing)	n/m	−51.55% (below 0%: shrinking)	76.08%	(160.94%)	Compare
AFIB Acutus Medical, Inc.	$1.7M	— (loss-making)	— (loss-making)	+204.18% (above 0%: growing)	n/m	+76.40% (above 0%: growing)	14.20%	(3.81%)	Compare
DHAI DIH Holding US, Inc.	$1.6M	— (loss-making)	—	−30.67% (below 0%: shrinking)	n/m	−167.90% (below 0%: shrinking)	50.33%	(33.62%)	Compare
DYNTQ Dynatronics Corporation	$1.2M	— (loss-making)	— (loss-making)	−7.61% (below 0%: shrinking)	n/m	−193.04% (below 0%: shrinking)	24.65%	(1.26%)
THMO ThermoGenesis Holdings, Inc.	$1.1M	— (loss-making)	5.5×	+6.42% (above 0%: growing)	n/m	+62.12% (above 0%: growing)	43.92%	(20.35%)	Compare
SSKN Strata Skin Sciences, Inc.	$1.0M	— (loss-making)	— (loss-making)	−2.97% (below 0%: shrinking)	n/m	−376.88% (below 0%: shrinking)	61.82%	7.66%	Compare
FEED ENvue Medical, Inc.	$950.0K	— (loss-making)	— (loss-making)	−51.62% (below 0%: shrinking)	n/m	+19.75% (above 0%: growing)	(111.30%)	(2,290.38%)	Compare
Median of peers	$1.6M	—	—	+6.42%	—	−13.87%	29.06%	(26.98%)

All 149 Medical Devices stocks →

Dynatronics Corporation (DYNTQ) key facts

Concern: Dynatronics Corporation’s revenue for fiscal 2025 (year ended June 2025) was $27.4 million, down 15.8% from fiscal 2024.
Dynatronics Corporation (DYNTQ) is a Medical Devices company in the Healthcare sector.
Return on equity was −1,588.4% and debt-to-equity 1.19.
Its Piotroski F-score is 3 out of 9 and its Altman Z-score is −2.33 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.